Tirzepatide access
Embody vs Mochi Health: Which One Offers Tirzepatide? (2026)
Embody or Mochi Health? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Embody and Mochi Health usually comes down to one difference that neither homepage puts in its headline.
Molecule availability is the fork here: Embody covers both semaglutide and tirzepatide, while Mochi Health publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Where a figure is not published, that is stated rather than estimated.
The short answer
- Lowest ongoing rate
- Embody — $69/mo against $99/mo, though only one of the two publishes enough to total a full year.
- Most support for the money
- Mochi Health — 24/7 support plus ongoing appointments throughout the program.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Embody — Neither publishes financing; both expect the full amount monthly.
The short version: Embody vs Mochi Health
The rows below are the ones that differ enough between these two to be worth your attention.
| Embody | Mochi Health | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | Membership plus medication from $99/mo, 50% off the first month |
| Rate after promotions | $69/mo | $99/mo |
| Pricing structure | Published rate per medication | Membership fee plus the cost of medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded GLP-1 |
| Tirzepatide | $119/mo | Not published |
| Membership fee | None | Yes, billed separately |
| How fast you start | Licensed provider review handled entirely online | Live video visit with a doctor, bookable in about 5 minutes |
| State coverage | Not published | All 50 states |
| Price transparency | Published upfront | Partly published |
| Patient reviews | 11,250 | 36,124 |
| eRxDoctor score | 7.6/10 | 7.0/10 |
Embody vs Mochi Health on total cost, not entry price
Comparing entry prices across these two would be actively misleading, because they escalate differently. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Embody | Mochi Health | |
|---|---|---|
| First month | $69 | $99 |
| Months 2 onward | $69/mo | Not published |
| 6-month total | $414 | Not computable |
| 12-month total | $828 | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Mochi Health: total monthly cost is membership plus medication and varies by plan and medication. Treat any comparison that quotes one as an estimate someone else has made for you.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
Embody publishes both, with tirzepatide at $119/mo. Mochi Health publishes compounded GLP-1, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
If you are confident semaglutide is where you will stay, this difference costs you nothing. If you are not, it is worth more than a small monthly saving.
Embody: what you are buying
Semaglutide $69/mo (was $299), Tirzepatide $119/mo What it is really selling here is the lowest published semaglutide price on this list, with no lock-in.
Getting started means licensed provider review handled entirely online, after which free shipping, 1-2 day delivery after approval. Pricing runs on a published rate per medication basis, published upfront.
Ongoing care is 24/7 support for dosing and side-effect questions, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Embody pros
- Licensed provider review handled entirely online
- 24/7 support access for dosing and side-effect questions
- Lowest entry price on this list at $69/month for compounded semaglutide
- Compounded tirzepatide available at $119/month
Embody cons
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- $69 semaglutide pricing is a limited-time offer that may increase
Against Mochi Health specifically, the trade you are making: a limited-time rate with few of the extras that higher-priced platforms bundle.
A closer look at Mochi Health
50% Off Your 1st Month with Code BESTWLHALFOFF In this pairing, its distinguishing feature is a live video visit with a doctor in about five minutes, where most competitors run an asynchronous text review.
Intake is live video visit with a doctor, bookable in about 5 minutes. Fulfillment is home delivery. The commercial terms are membership fee plus the cost of medication, partly published.
Support: 24/7 support plus ongoing appointments throughout the program. The medications on offer are compounded GLP-1.
Mochi Health pros
- 50% off your first month with code BESTWLHALFOFF
- Live video visits with a doctor, bookable in about 5 minutes (most competitors do async text review)
- 24/7 support plus ongoing appointment availability throughout your program
- Reliable GLP-1 prescription access in all 50 states
Mochi Health cons
- Pricing is membership plus medication, so total monthly cost varies by plan and medication
- Ongoing pricing is less transparent than flat-rate competitors
- Compounded medication focus, branded options not the primary offering
The cost of choosing this over Embody: membership-plus-medication pricing is harder to forecast than a flat rate.
Who should choose Embody, and who should choose Mochi Health
Choose Embody if:
- the monthly rate is the constraint — $69/mo against $99/mo
- you want tirzepatide available without changing provider later
- you want the full price in front of you before completing an intake
- you want a single monthly charge rather than a membership plus medication
Choose Mochi Health if:
- you want to start on their timeline: live video visit with a doctor, bookable in about 5 minutes
- the level of clinical contact suits you: 24/7 support plus ongoing appointments throughout the program
- the feature you would actually use: a live video visit with a doctor in about five minutes, where most competitors run an asynchronous text review
- you are in a state where GLP-1 telehealth coverage is patchy
What each one gives up
On price. Embody is the cheaper program at $69/mo against $99/mo. What Embody gives up for that is a limited-time rate with few of the extras that higher-priced platforms bundle; what Mochi Health charges for is a live video visit with a doctor in about five minutes, where most competitors run an asynchronous text review.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — 24/7 support for dosing and side-effect questions against 24/7 support plus ongoing appointments throughout the program — and that difference is felt in week two, not week one.
On medication. Embody covers compounded semaglutide and compounded tirzepatide; Mochi Health covers compounded GLP-1. Only Embody publishes a tirzepatide route, which matters if semaglutide underdelivers.
The medication, not the platform
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Embody vs Mochi Health: common questions
What happens when Embody's promotional price ends?
The rate moves to $69/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which is cheaper to start, Embody or Mochi Health?
Embody, at $69 against $99. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which has more patient reviews, Embody or Mochi Health?
Mochi Health, with 36,124 against 11,250. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Embody or Mochi Health take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Does Embody or Mochi Health charge a membership fee?
Mochi Health runs a membership-plus-medication model, so the monthly total is the membership plus whatever the medication costs on your plan. Embody charges $69/mo with no separate membership. When comparing the two, price the membership model at your expected maintenance dose rather than at the introductory rate.
How fast can I start with Embody compared with Mochi Health?
Embody advertises licensed provider review handled entirely online, with free shipping, 1-2 day delivery after approval. Mochi Health advertises live video visit with a doctor, bookable in about 5 minutes, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Are Embody and Mochi Health legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Embody operates on published rate per medication with pricing published upfront, Mochi Health on membership fee plus the cost of medication, partly published. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Embody is the cheaper of the two to run at $69/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
Mochi Health's case is a live video visit with a doctor in about five minutes, where most competitors run an asynchronous text review; its cost: membership-plus-medication pricing is harder to forecast than a flat rate.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Embody vs MaximusBudget vs premium
- Embody vs He & She MDBudget vs premium
- Gala vs Mochi HealthBudget vs premium
- Measured vs Mochi HealthTirzepatide access
- Yucca Health vs MaximusTirzepatide access
- Yucca Health vs TMatesTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or Mochi Health, and does not sell treatment. Read our ranking methodology.